Individuals who share a disease mutation from a common ancestor often share alleles at genetic markers adjacent to the mutation, even if the common ancestor is remote. The alleles at these adjacent markers, called the haplotype, can be visualized as a string of realizations of random variables, which may be dependent when individuals are related in some fashion. Ideally, for a sample of individuals all having the same (genetic) disease, this dependence-measured as haplotype-sharing-will be greater in the vicinity of disease genes than in other regions of the genome. In this paper we present a semiparametric test for haplotype-sharing. We begin by developing a model assuming that the ancestral haplotype is known and thus the extent of haplotype-sharing from a common ancestor can be determined unambiguously. The amount of overlap at markers far from the disease is treated as a random variable with an unknown distribution F, which we estimate non-parametrically. Overlap of markers surrounding disease genes are modeled as a mixture pF(x − θ) + (1 − p) F(x), in which p is the fraction of subjects with the disease mutation. Testing for a disease gene then amounts to testing whether p = 0. Next we drop the assumption that the ancestral haplotype is known. To detect excess clustering of haplotypes, we measure the pairwise overlap of a set of haplotypes. As in the simpler scenario, this distribution is modeled as a location-shift mixture. To test the hypothesis we construct a score test with a simple limiting distribution.
INTRODUCTION
Genetic epidemiologists tend to classify diseases into two types, simple and complex, depending on whether or not the mode of inheritance can be determined from the pattern of affected and unaffected individuals within families. By the concerted efforts of scientists from various disciplines, many genes underlying simple genetic diseases have been uncovered. The discovery rate for genes affecting simple diseases will accelerate during the near term, until few such genes remain unknown. For complex diseases, however, the picture is not so rosy. In fact, despite substantial effort, only a small set of the genes underlying Alzheimer's and coronary heart disease have been uncovered, and none have been found for common mental disorders such as schizophrenia.
Viewed in historical perspective, the current intractability of the problem of complex disorders is unsurprising. Only recently has the yield of genes underlying simple genetic disorders been substantial, and that came after a revolution in molecular and statistical tools for gene discovery. Arguably it will take another revolution to have the same yield for complex diseases. In fact, we believe the revolution is upon us: the new molecular tools will include the sequence of the human genome, at least in rough form, a dense set of genetic markers covering the genome, technologies for inexpensive analysis of genetic markers and gene expression, and so on. Statistical analysis will follow suit, with perhaps one major shift being a de-emphasis on pure linkage strategies and far greater emphasis on association analyses such as casecontrol and transmission disequibrium tests (TDT) (the geneticists' version of matched case-control). But successful association analyses will be on a grand scale, and what form these analyses will take is still unresolved.
In a recent article, Devlin and Roeder (1999) outline an association method for both genome-wide and candidate gene studies. Called 'genomic control', their method permits analysis of heterogeneous case-control designs without the usual increase in the false positive rate. The method uses data from single nucleotide polymorphisms (or SNPs), analyzed by Armitage's trend test (Armitage, 1955) , with statistic Y 2 i calculated for each marker i. Due to non-independence in the sample, arising from population heterogeneity and/or cryptic relatedness, the null model has assumed form Y 2 i ∼ λχ 2 1 for some λ > 0. To allow for outliers (i.e. markers associated with the disorder) the model is enhanced so that the distribution for Y 2 i is a mixture of chi-square distributions:
, where is the prior probability a given observation is an outlier and A 2 i is the non-centrality parameter associated with the ith outlier. Estimation for the model depends on whether the study design targets genome-wide association or candidate genes. Devlin and Roeder present both Bayesian outlier (adapting from work by Verdinelli and Wasserman, 1991) and frequentist procedures.
While the genomic control method presented by Devlin and Roeder has many advantages, it treats each marker as independent. If the markers were correlated due to proximity on the chromosome, this strategy can be inefficient. It is difficult to predict the degree of correlation among markers on chromosomes because it depends on an unknown, historical process of evolution and inherent, often unknown, features of the chromosomes themselves. We anticipate that accounting for the spatial proximity of markers will lead to increased power to detect genes underlying complex diseases in some and perhaps many instances. In this article, we build the framework for genomic control taking into account the spatial relationships among markers. Specifically, we propose methods that jointly analyze an ordered set of genetic markers known as a haplotype (see Table 1 ). There is usually no reason to presume the disease mutation corresponds to any of the observed markers in the haplotype; instead it will usually fall between measured markers. Our goal is to discover if disease mutations are embedded in the haplotype of markers.
GENETIC BACKGROUND
Genetic markers are distributed at high density throughout the human genome. If chosen at random, alleles at any two of these markers are likely to be independent because the markers lie on different chromosomes or far apart on the same chromosome. However, alleles at markers in close proximity on a chromosome often are not independent, and geneticists say the alleles are in linkage disequilibrium within the population. The term 'linkage disequilibrium' explains the phenomenon that generates it-the alleles at different markers are physically linked by chromosomal material. Recombination breaks up dependent alleles, but the probability of recombination events between proximate markers is small; the probability of recombination events over small intervals defines the genetic distance. When a new disease mutation occurs on a chromosome, the mutation is initially in complete disequilibrium with all other alleles on the chromosome (i.e. the disease mutation is only observed in association with a particular haplotype). The disequilibrium among distant alleles breaks down quickly due to recombinations, but the erosion is slow for alleles near the disease locus. Thus it is anticipated that marker alleles near disease genes will be in linkage disequilibrium with disease alleles. In other words, if marker haplotypes were examined, at least one haplotype, and possibly more, would be found to be associated with the disease allele (see Table 1 ), but the disease mutation itself would typically not be observed. The length of the haplotype associated with the disease mutation depends upon the age of the mutation.
Indeed, this expectation is realized. For genes underlying simple diseases, it is common for individuals sharing a genetic disorder to share alleles in the haplotype defined by the genetic markers flanking the disease gene. Certain haplotypes are highly associated with the disease alleles for cystic fibrosis, diastrophic dysplasia, limb-girdle muscular dystrophy, phenylketonuria, Friedreich ataxia hereditary haemochromotosis, late-onset Alzheimer's, and many other disorders (de la Chapelle and Wright, 1998, and references therein). In some cases, the associated haplotypes vary by population and by the disease mutation. For complex disorders, such as diabetes, we expect a great deal of heterogeneity even within a common population. Nevertheless, based on theory and practice, we expect in some cases to find disproportionally large clusters of individuals sharing common haplotypes in the region flanking the disease mutation. Indeed, two genes affecting intrahepatic cholestasis (Houwen et al., 1994) and Hirshsprung disease (Puffenberger et al., 1994) have been mapped by evaluating the degree of haplotype-sharing among cases for various regions of the genome. Several procedures have been proposed that are based upon detecting excess clustering of common haplotypes in a sample of diseased individuals (e.g. Van der Meulen and Te Meermen, 1997) . Using direct identity-by-descent mapping, Grant et al. (1999) search for regions in the genome over which there are significantly more matching segments than expected. Using the same principles, (McPeek and Strahs, 1999) model the decay of haplotype-sharing to fine map disease genes.
How should one evaluate the extent of haplotype-sharing? When the genealogical structure within a particular region is known, simulation (Houwen et al., 1994) or approximation (Durham and Feingold, 1997) methods can measure the expected amount of haplotype-sharing within a particular region. Naturally, this expectation can be contrasted with the observed data, producing an approximate significance test. For many complex diseases, however, the genealogy will not be known or it will be at best partially known. Instead one might look for a control sample to evaluate its degree of haplotype-sharing. Unfortunately that comparison may not be satisfactory for a reason that often goes unrecognized in association analysis. The difficulty is the implicit assumption that the subjects are independent in both control and case samples. A random collection of controls probably meets this assumption, at least approximately. But how credible is the assumption for the case samples who share a genetic disorder? While the degree of credibility is unknown, it is reasonable to suspect that those affected are more closely related than is the control sample. To combat the potential bias induced we propose a method that utilizes genomic control (Devlin and Roeder, 1999) .
We propose to compare the degree of haplotype-sharing in a sample of cases measured at many regions across the genome: one or more regions is believed to harbor a gene-affecting liability and other regions are unlikely to carry such genes. Thus, by design, the cases provide their own controls. We define sharing between a pair of haplotypes as the portion of the haplotypes which are identical by descent (ibd, i.e. the portion of the haplotype, or chromosome, identically inherited from a common ancestor).
Understanding the genealogical relationships among a sample of homologous chromosomal segments has been the subject of intense study, developing into the theory of the coalescent (Kingman, 1982) . The distribution of ibd sharing from a most recent common ancestor is roughly constant across the genome (Wiuf and Hein, 1999) . The more recent the ancestor, the larger the region of haplotype that is shared ibd. From these results we infer that it is possible to construct controls from cases by utilizing segments of the genome that do not contain any genes contributing substantially to the risk for the genetic disease under study. By essentially conditioning on the genealogy of the sample, any bias induced by cryptic relatedness will be removed. For instance, the amount of ibd sharing among sixth cousins in the sample will be roughly constant across regions of the genome not possessing a genetic mutation related to the disorder under study.
A key feature of our model is that regardless of their genealogy, two individuals who share a genetic mutation ibd are likely to share a greater portion of the region surrounding a mutation. This result also follows from the theory of the coalescent. Hence, the expected level of sharing is inflated in the region of interest, although sharing may be minimal for ancient mutations.
Naturally, the ibd status of pairs of haplotypes is unobservable. In fact, for most proposed studies, genotypes rather than haplotypes will be measured. In this article we describe how data with known ibd status could be analyzed based on the models we develop. Thus we assume that haplotypes from many regions of equal 'genetic length' (measured in terms of genetic distance) are under investigation and that the length of the region's shared ibd among pairs of haplotypes is measurable. In a follow-up paper we investigate suitable proxies for the measure of ibd status between haplotypes. Table 2 illustrates the data summary obtained from the haplotypes displayed in Table 1 . In Tables 1 and 2 , for the purpose of illustration, matching markers are assumed to be ibd, although clearly some matching would occur due to chance alone.
We envision applying these methods to an experiment in which haplotypes are measured for several candidate regions and several regions believed from prior studies to not possess any genes for the disease under investigation. The haplotypes from the candidate regions define the 'cases' and the remaining haplotypes define the 'controls'. A haplotype is defined as a segment of the chromosome short enough to presumably maintain disequilibrium for a disease of relatively recent origin (e.g. 1 cM-approximately 1 Mb-for a mutation arising within the past few hundred generations). The length of the measured haplotype defines the length of the region. In Sections 3 and 4, we propose statistics to test for mutations in a single disease gene (i.e. in a single region of the genome). An extension to detect multiple-disease genes in different regions is developed in Section 5.
SCORE TEST FOR EXCESS OVERLAP
For expository purposes, in this section we assume that a disease mutation occurred only once during the past. Then this ancestral haplotype gave rise to all haplotypes bearing the disease mutations. This model, while clearly artificial, will facilitate the development of more general statistical methods in Section 4. We begin this section by developing a mixture model that follows naturally from the genetic model (Section 3.1). Under the alternative hypothesis the lengths of ibd sharing between the observed and the ancestral haplotypes are distributed as a location mixture, with p haplotypes descending from the ancestral and 1 − p haplotypes of other origins. To test for the presence of a mixture, we use the score test developed by Liang and Rathouz (1999) (Section 3.2). Finally we extend the methods to allow for non-parametric estimation of the mixture component distribution (Section 3.3).
Notation and probability model
For this analysis, suppose n/2 individuals affected by the same disease are sampled. This yields n observations since each individual contributes two chromosomes. Let V 1 , . . . , V n denote the haplotypes obtained from a region which might contain a disease mutation (the cases) and let 
denote the haplotypes from a set of K regions assumed not to contain the disease gene (the controls), where U ik is the haplotype of the ith individual in the kth region. Let A and A k denote the ancestral haplotype in the region of interest and in the null region k, respectively. (Although the concept of an ancestral haplotype is somewhat artificial when there is no disease mutation present, these quantities are treated as known constants for expository purposes.) Let
the amount of overlap between the ith haplotype and the ancestral haplotype; i.e. the length the pair of haplotypes share ibd. The sample of case and control haplotypes generates measures of overlap that we label
Note that X has m n = K n elements and Y has n elements. Let F denote the marginal distribution of the control overlaps, X ik , and let G denote the marginal distribution of the case overlaps, Y i . If a disease mutation is present at the site where Y is obtained, then some fraction p of pairs of haplotypes will have larger overlaps than expected under F (corresponding to the fraction of people with the disease mutation).
Because of the heterogeneity of complex diseases, it is very unlikely that p will be one. In other words, some people will have the disease for other reasons and hence will not have the disease mutation in either of their haplotypes. The remaining 1 − p overlap pairs are expected to follow the same distribution as the controls, F. This means that G should be a mixture of F and some other distribution H . We expect excess sharing so H should be stochastically larger than F. As a working model for H we propose a location shift model,
We want to test
Here, F is an arbitrary distribution with density f . (Some regularity conditions are imposed on F below.) Note that the alternative is semiparametric. A fully non-parametric alternative of the form
is not identifiable. However, the semiparametric model is fully nonparametric under H 0 . Thus, if the alternative is misspecified, we may lose power but the test remains valid under the null hypothesis. We ignore the constraint that θ is expected to be positive under H 1 until later.
Independent case with F known
Suppose that F is known and has density f . Let
It has long been recognized that the standard asymptotic approaches to hypothesis testing do not apply to mixture models (Davies, 1977) because the nuisance parameter θ disappears from the likelihood under the null model. To overcome this problem Liang and Rathouz (1999) propose a simple solution based on a modification of the typical score test. The score function for p evaluated at p = 0 and a fixed value of θ is given by
Liang and Rathouz suggest arbitrarily fixing p at some positive value p = p 0 ∈ (0, 1] and then estimating θ assuming the model G(·; p 0 , θ). Substituting a carefully chosen, unconstrained, estimateθ for θ into the unnormalized score function (2) results in a test statistic that follows a χ 2 1 distribution in the limit. For our purposes we defineθ
where
This is an approximate maximum likelihood estimate for θ under p 0 = 1; see the comment below. Note that
is the Fisher information for θ under the null model, if p is fixed at 1. Assuming smoothness conditions on f , S n (θ) converges to a χ 2 1 . We can show this result by applying the same argument as in Liang and Rathouz (1999) :
REMARK. As noted by Liang and Rathouz (1999) , we can plug in the maximum likelihood estimate of θ for any fixed value of p, 0 < p ≤ 1, in the likelihood under G(·; p, θ). Clearly p = 1 provides the most convenient model choice for computational efficiency. The estimatorθ given in (3) is asymptotically equivalent to −˙ (0)/¨ (0), which is the one-step estimator starting at θ = 0, provided we treated (θ ) as a log-likelihood function. A one-step estimator provides even greater computational efficiency than the maximum likelihood estimator. Also note that ifθ is constrained to be non-negative, then the limiting distribution is a 50 : 50 mixture of chi-square distributions with zero and one degrees of freedom.
Independent case, F unknown
Now suppose that f is unknown. We will use X m = (X 1 , . . . , X m ) to estimate f and f with kernel density estimators and insert these estimates into (3) and (2) to obtain the score test S n (θ). Note that X m represents the data in X expressed as a single vector. Thus, let κ(·) be a kernel satisfying κ(y) dy = 1, yκ(y) dy = 0 and y 2 κ(y) dy > 0. Definê
where the optimal bandwidth h r with respect to mean squared error loss for the r th derivative is (Silverman, 1986) . Here, R(φ) = φ 2 , A r = ( f (r +2) ) 2 and µ 2 = x 2 κ(x) dx. In practice, we use any bandwidth of the form h r = O(m −1/(5+2r ) ). Note that the estimate of the derivative of the density is based on a separate estimator: it is not simply the derivative of the estimate of f . We need to do this since the optimal bandwidth for estimating a derivative of the density is different than the optimal bandwidth for estimating the density. In what follows, we will assume that f and f are bounded above by B < ∞ and that f is bounded below by δ > 0. We will writeθ asθ( f ) when we want to make it explicit thatθ , as defined in (3), is a function of f . Similarly, we write S n (θ, f ) to make the dependence of the score on f explicit. Note that there are two sample sizes m and n. In the asymptotic arguments that follow, n and m will both increase. Since the relative rate at which these increase is important, we explicitly write m n . REMARK. The condition that n/m 2/7 → 0 is equivalent to n = o(K 2/5 ), which means that K must be much larger than n 5/2 . In practice, this would not be feasible. If we use a higher order kernel κ, then the sample size requirements are reduced. Recall that κ is a dth order kernel if xκ(
In that case, the kernel estimate of the r th derivative has a mean square error (MSE) of order n −2d/(2d+2r +1) . As a result, condition (5) becomes n/m d/(2d+3) → 0. For large d this says that m = K n must be just slightly larger than O(n 2 ). Consequently it suffices to let K grow slightly faster than n, say c n log n, to obtain the desired limiting results. In our experience, however, we found that the usual second order kernels (used in Theorem 1) suffice to make the score test approximately χ 2 1 for reasonable sample sizes. For instance, we found that with n = 100 and K = 10 the test achieved the desired distribution, but with K = 1 it did not.
We claim that
To see this, note that
Now f (Y i ) ≥ δ and, because f is bounded from below and the sample space is compact, it follows that f converges to f uniformly if the bandwidths are chosen as above. The uniform consistency off implies that, for large n,f (Y i ) ≥ δ a.s. for all i. So, almost surely, for large n,
because the integrated mean squared error of the kernel density estimate is of order O(m
since the integrated MSE of the kernel density estimate of f is of order O(m
Now we examine the score statistic. Let θ ≡θ(f ) andθ ≡θ( f ). We have
where S n ≡ S n (θ( f ), f ) and
Since, S n ( f ) → χ 2 1 , it suffices to show that A n = O P (1). Arguing as above, and using the fact that sup x | f (x)| ≤ B, we see that, for large n,
It follows from Silverman (1978) that
and (5), we see that A n = O P (1).
SCORE TEST FOR EXCESS OVERLAP AMONG HAPLOTYPES
In this section we drop the assumption that the ancestral haplotype is known. To detect excess clustering of haplotypes, we make all pairwise comparisons among haplotypes within a region. Because the resulting data are dependent, the results of Section 3 will be extended using the properties of U-statistics.
Notation and probability model
To extend the notation from Section 3, let X i jk = [U ik ∩ U jk ], k = 1, . . . , K , denote the amount of overlap between two observed haplotypes. The sample of case and control haplotypes generate measures of overlap that we label
Note that X has m n = K n(n − 1)/2 elements and Y has n(n − 1)/2 elements.
Some pairs of individuals in our sample will have a close genetic relationship and hence will exhibit a great deal of overlap across many regions, while others are distantly related and their haplotypes will exhibit very little overlap. In practice we adjust for relatedness by subtracting the 'pair effect' from X i jk and Y i j . (See the example in Section 7 for further discussion.) Let F denote the marginal distribution of the corrected overlap of the controls X i jk , and let G denote the marginal distribution of the corrected overlap of the cases, Y i j . Throughout the remainder of this article we assume that the overlaps have been corrected for the level of relatedness and drop the terminology.
If a disease mutation is present at the site where Y is obtained, then by assumption some fraction p of pairs of haplotypes will have larger overlaps than expected under F. Because we now consider pairwise overlaps and allow for multiple ancestral backgrounds, p no longer corresponds directly to the fraction of people with the disease mutation. If there are several ancestral haplotypes, then a cluster of overlaps for each ancestral type will be obtained that is stochastically larger than expected. This fraction, p, is slightly less than the squared sum of the relative frequency of each cluster.
The remaining 1 − p overlap pairs derive from three distinct comparisons: (i) disease mutations are absent from both haplotypes; (ii) one haplotype carries a disease mutation whereas the other does not; and (iii) both haplotypes possess a disease mutation, but the mutations are embedded in different ancestral haplotypes. We assume the overlaps for pairs from all three of these types follow approximately the same distribution as the controls, F. This is a key assumption of our analysis. While case (i) follows trivially, the other two cases are not obvious.
For association analysis to be powerful, it is necessary that clusters of diseased individuals derive from common ancestry at some point in the (distant) past. Without this assumption there is no reason to expect a fraction of disease mutations to be embedded in a small number of common ancestral haplotypes. These ancestral 'disease' haplotypes most often derive from common 'normal' haplotypes. For this reason there may be some overlap among many of the haplotypes in the sample, even from different ancestral haplotypes that are progenitors of clusters of disease mutations. See Tables 1 and 2 for an example.
When subsets of haplotypes are collected from populations of essentially distinct heritage we expect very little overlap across clusters. From this fact it is tempting to conclude that the overlap distributions will be stochastically smaller than F under cases (ii) and (iii). However, if haplotypes i and j derive from distinct populations, then the uncorrected overlaps for this pair, {Y i j , X i jk , k = 1, . . . , K }, will be stochastically smaller than average for every region under study-not just in the region of interest. By estimating F using corrected overlaps, we bypass this problem of differing levels of relatedness among the sampled haplotypes altogether. Thus under typical evolutionary scenarios the key assumption of our analysis is plausible. If the assumption fails, then our method is robust, but tends to lose power.
Non-independent case
As in the independent case, we wish to test the hypothesis specified in (1) for our redefined terms. We initially assume that f , the density of F, is known. The results are then extended to the semiparametric case, as in Section 3. In the discussion below assume all expectations are taken at the null hypothesis. Recall that V i denotes the ith haplotype and
Define the U-statistic version of the score function (2) as:
and
Applying Hajek's projection theorem, we approximate , 1998, Theorem 12.3) . Under standard regularity conditions the equivalent result holds for the derivatives with respect to θ . Define
, and we can treat these terms as asymptotically equivalent in the derivation below. By the central limit theorem,
As before, we seek an estimator of θ that is well behaved when θ = 0 in the sense that
To this end, defineθ
Finally we expand S n (θ) about θ = 0 to obtain the asymptotic distribution of the score statistic:
It follows from (8) and (9) that S n (θ) converges in distribution to χ 2 1 . To obtain a statistic which can be computed in practice, replace ζ with ζ n as defined in (7). This approximation derives from the representation of ζ given in van der Vaart (1998, p. 162) :
This quantity can be approximated by a third degree U-statistic provided the kernel is symmetrized; see (7). The limiting distribution is still χ 2 1 by Slutzky's Theorem.
If f is unknown, we proceed as before, using a kernel estimate of the form:
THEOREM 3. Define S n as in (6) REMARK. Ifθ is constrained to be non-negative, then the limiting distribution is a 50 : 50 mixture of chi-square distributions with zero and one degrees of freedom. This result follows from the usual argument; see Liang and Rathouz (1999) .
The properties of density estimators of functions of observations, such as the various measures of overlap we have considered, are thoroughly investigated by Frees (1994) . He obtains some surprisingly powerful results. Under fairly weak conditions, U-statistic-density estimators, such as the one described above, are shown to converge at a root-m rate. Recall that m = K n in our application. Consequently, just as we found with higher order kernels in the independent case, it suffices to let K grow slightly faster than n, say c n log n, to obtain the desired limiting results. Frees also shows that not all pairwise observations need be included in the calculation; it suffices to take a random sample of R m terms, provided R m /(m/ h m ) 2 → ∞. The optimal choice of h m is smaller than for the usual density estimator: we require h m = O(m −1/4 ) and mh m → ∞. These two results combined help to make this procedure computationally feasible.
MULTIPLE TESTING
In practice we may test many candidate regions R 1 , . . . , R g for disease mutations. We continue to let X represent the overlaps from a fixed set of controls. Each region being tested gives rises to sets of overlaps Y 1 , . . . , Y g . Each region then yields a score statistic S 1 , . . . , S g with corresponding p-values p 1 , . . . , p g . From the results in the previous section, each p-value is approximately uniformly distributed if no disease mutation is present. For simplicity, we assume in this section that they are exactly uniform under the null hypothesis.
If g is large, it is important to protect ourselves from false rejections due to multiple testing. The conventional method is Bonferroni where the null hypothesis for the jth region is rejected if p j < α/g where α is the desired type I error rate. This approach is very conservative. In many cases, it is more appropriate to control the false discovery rate (FDR), which is defined to be the number of false rejections divided by the number of rejections. Notice that Bonferroni (and related methods) controls the overall error rate, i.e. the chance of making any false rejections. Controlling the FDR automatically controls the overall error rate in the special case that all the null hypotheses are true. But when some hypotheses are false, the two goals differ. Controlling the FDR means controlling the fraction of false rejections which often seems more reasonable when conducting a large number of tests. For this reason we suggest controlling the FDR using the procedure due to Benjamini and Hochberg (1995) and Benjamini and Yekutieli (1999) .
Let p (1) , . . . , p (g) be the ordered p-values and R (1) , . . . , R (g) be the regions arranged in corresponding order.
we reject all hypotheses before R (i * ) . Let R be the number of hypotheses rejected and R * the number of false rejections so that Q = R * /R is the false discovery rate. If the above procedure is followed, then Benjamini and Hochberg (1995) and Benjamini and Yekutieli (1999) proved that E(Q) ≤ α. We illustrate the procedure in Section 7.
If the tests are dependent, as they are in our case, choosing
(1/i) protects the FDR at level α. However, if the tests are independent or if they are dependent in a special way, called 'positive regression dependence', then one may use C g = 1; see Benjamini and Yekutieli (1999) for details. This choice gives a more powerful test. We conjecture that our tests are positive regression dependent, at least asymptotically, but so far we have no proof. This leaves open the question of whether we should use
(1/i), which guarantees control of the FDR, or C g = 1, which gives more power. For the examples in Section 7, we consider both. In this section we describe a modest simulation study to provide evidence that the limiting χ 2 1 distribution of the score test under H 0 is a reasonable approximation. The case where f is known and the data are independent and identically distributed (i.i.d.) has been investigated by Liang and Rathouz (1999) . We are interested in the effects of the two generalizations developed herein, namely estimating f non-parametrically and using the U-statistic version for the dependent case. CASE 1. Data are i.i.d., f is estimated non-parametrically. We generate n = 100 and m = 1000 observations from a normal distribution. Kernel density estimates were used and the bandwidths for f and f were based on the normal reference rule in Silverman (1986) . The results, based on 10 000 replications, are in Table 3 . The test statistic was also investigated using a gamma distribution and the results (not displayed) were essentially identical. CASE 2. U-statistic version, f known. Each haplotype was generated as a string of M 0s and 1s drawn independently from a Bernoulli (q). We used M = 100 and q = 0.2. The overlap at any location was Bernoulli with probability t = q 2 + (1 − q) 2 , and thus the overlap was approximately N (Mt, Mt (1 − t) ). For the purposes of the simulation we took f to be this normal density. The results, based on 10 000 replications, are in Table 3 .
The simulations confirm that the limiting distribution is a reasonable approximation. It appears in the U-statistic case that the approximation is less accurate but tends to err in the direction of being slightly conservative. Based on these simulations and our theoretical results it is reasonable to expect that the distribution of the test statistic described in Theorem 3 will also be somewhat conservative for small samples. This test statistic cannot be investigated via simulations because it requires much computing time. The next section considers some examples under H 1 .
EXAMPLE
To generate data possessing some of the features observed in a population of haplotypes, we used a statistical model. For simplicity, we ignore the natural pairing of haplotypes within an individual, generating n = 100 haplotypes for 15 different regions of the genome. No disease gene is present for 10 of these regions; thus haplotype-sharing therein estimates the baseline overlap distribution. Five candidate regions were simulated under the alternative hypothesis. For these haplotypes a greater level of overlap is expected among a small cluster of the haplotypes.
Haplotypes are generated as a string of length M = 100 consisting of M 0s and 1s. The number of markers at which a pair of haplotypes match is used as a proxy for ibd overlap. The purpose of genomic control is to capture the unobserved background relatedness of the individuals in the sample by comparing the distribution of overlaps across regions. Those individuals who are closely (distantly) related will tend to have more (less) than the average amount of overlap uniformly across the genome. To generate different levels of relatedness amongst the simulated sample, we associate a q i with each of the i samples, i = 1, . . . , n; q i ∼ beta (12, 8) . Within the ith haplotype, U ik is a string of independent Bernoulli trials with parameter q i . Those pairs (U ik , U jk ) with q i similar to q j will tend to have substantial overlap and those with dissimilar qs will tend to have little overlap. By using the same vector q = (q 1 , . . . , q n ) for each sampled region this feature is carried across all sampled regions much like the actual ibd sharing we wish to mimic. For instance, if samples i and j come from cousins, then they are likely to share a substantial portion of their haplotypes in all regions. We simulate this relatedness when q i and q j are both close to either 0 or 1.
For the null distribution we sampled n haplotypes at each of 10 regions using q for each region. Based on these 10n haplotypes, a set of 10n(n − 1)/2 measures of overlap X i jk are obtained. For each of the five candidate regions we aim to simulate a randomly-selected cluster of haplotypes of size B j , j = 1, . . . , 5, which share a disease mutation from a common ancestor. Hence we modify the vector q by changing q i for B j randomly selected haplotypes to equal a common value close to one (e.g. q i = 0.9). This perturbation generates a cluster of haplotypes with substantial overlap. For each simulated region of interest we generate only one cluster, but for actual data there may be multiple clusters.
The K +1 overlap measures from a pair of individuals, Y i j , X i j1 , . . . , X i j K , are correlated because they share a common parameter (q i , q j ), which reflects the level of relatedness of the pair. To partially adjust for levels of relatedness, we subtractX i j. = 1 K X i jk from each observation. This is what we referred to previously as a corrected-overlap measure. With this adjustment, the observations are approximately independent and centered at zero under the null hypothesis. By removing the 'pair effect', the procedure gains power by reducing the variance of the overlap distribution.
The simulated overlap distributions are displayed in five panels of Figure 1 , in which the density of Y i j −X i j. is contrasted with the density of X ik −X i j. . For these panels a small bump of 'excess overlap' is present to the right of the bulk of the density. The strength of the signal increases from top to bottom panel. The signal is weaker if either B decreases or q approaches 0.5.
Estimates of f and f are computed from the 10 null regions. When computing the smoothing parameter we take the sample size in (4) to be the number of independent observations, 10n. A numerical difficulty occurs when computing both the score function (6) and denominator ofθ. For values of Y i j in the tails of the density, the summands blows up iff (Y i j ) is too small. This situation is reminiscent of the problem of choosing adaptive bandwidths in kernel density estimation as in Abramson (1982) , in which the bandwidth h(x) at x is taken to be proportional to 1/ f (x), andf is a pilot density estimator. Wheñ f gets too small, h(x) blows up. A practical solution suggested by Abramson and others is to clip the density estimate. We adopt a similar approach here by truncating the density estimate below at 0.00001.
Under the alternative hypothesis θ is restricted to be non-negative. Consequently the limiting distribution under the null follows a mixture distribution, 1/2δ 0 + 1/2χ 2 1 , where δ 0 is a point mass at 0. Using a Bonferroni correction we find that three out of five of the candidate regions demonstrate significant association at the 0.05 level, but following either FDR procedure described above we identify four candidate regions for further investigation (Table 4) . These simulations were performed with small sample sizes (n = 100) and yet we obtain good power to detect a cluster involving 10% of the haplotypes. With larger sample sizes more modest deviations from the null were detectable, including deviations involving multiple small clusters (results not shown).
For these data the null distribution is approximately normally distributed and (4) provides a near opti- Table 4. mal choice of bandwidth. Because the test is non-parametric under the null hypothesis, normality is not required; however, we believe the test may perform better if the null data are transformed to approximate normality.
CONCLUDING REMARKS
We have developed a semiparametric score test to detect chromosomal regions harboring disease mutations based on haplotype-sharing data. We assume that regions bearing disease mutations are more likely to be identical (-by-descent or ibd) than those that do not, so that the entire data on haplotype overlap can be represented as mixtures. The test is based on an extension of the score test for mixtures developed by Liang and Rathouz (1999) . The extension is novel in two ways: (i) the form of the mixture component density is estimated non-parametrically; and (ii) the score test, which is based on pairwise overlaps, is a U-statistic.
The approach presented herein assumes knowledge of continuous ibd within regions; however, such knowledge is unlikely to be complete. Instead, a non-dense set of discrete markers will be observed and ibd status among pairs of haplotypes must be inferred. For another common data structure, only genotypes (rather than haplotypes) will be observed. For either case, proxies for ibd status such as measure of overlap will be required. In this article we use the total count of shared alleles to illustrate the procedure, but there is good reason to suspect that this is not the optimal proxy for ibd status. For instance, one continuous interval of matching alleles is more suggestive of ibd status than several disjoint intervals which sum up to the same length. We will explore such measures in a future paper. Direct ibd gene mapping provides an alternative to genetic marker data as a means for determining ibd status. Direct ibd mapping is a combination of DNA microarray technology and genomic mismatch scanning; see Cheung and Nelson (1998) and references therein for a description of the technique. Unlike genotyping, this technology is relatively expensive to perform at the present time. Because a separate laboratory experiment is required for each pairwise comparison of haplotypes, it may not be practical to obtain all pairwise comparisons of genetic material. Grant et al. (1999) propose a method of analysis that utilizes a single arbitrary choice of pairings which produces n/2 measures of overlap. To exploit this type of data our method could be modified to utilize a fraction of the set of all pairwise comparisons of haplotypes.
It should be possible to obtain a more powerful test by estimating the null density simultaneously from the null and alternative data. We have chosen a two-step procedure for simplicity. Modern semiparametric theory suggests the two-step procedure is not fully efficient; however, some caution is warranted. The parametric part of the model (the mixture) does not satisfy standard regularity conditions and it is not immediately obvious how to apply semiparametric methods to this case.
In some situations, the first order asymptotic arguments in Section 4 do not suffice. For example, in Section 6, Case 2, if we set q = 0.5, it can be shown that the U-statistic has a degenerate limiting firstorder approximation. In principle, these exceptional cases are a set of measure 0, and thus can be ignored. However, it is worthwhile noting this property for experimentalists, who might inadvertently design a study close to this peculiar boundary.
The methods described in this paper apply for both candidate genes and candidate regions (as would be obtained from linkage analysis). Our method assumes there is a known set of regions with no disease mutations. We are currently developing an extension to the FDR method in which the subset of regions with no disease mutation is unknown. This extension will allow us to extend our work to genome-wide searches for disease mutations.
